Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pranshu Mohindra, MD"'
Autor:
Pouya Sabouri, PhD, Jason Molitoris, MD, PhD, Maida Ranjbar, PhD, Julie Moreau, BS, Charles B. Simone, II, MD, Pranshu Mohindra, MD, MBBS, Katja Langen, PhD, Sina Mossahebi, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 3, Pp 101392- (2024)
Purpose: Breath-hold (BH) technique can mitigate target motion, minimize target margins, reduce normal tissue doses, and lower the effect of interplay effects with intensity-modulated proton therapy (IMPT). This study presents dosimetric comparisons
Externí odkaz:
https://doaj.org/article/256db647f92543d3a22d429bc8ec1fb9
Autor:
Ariel E. Pollock, MD, Hunter Risher, BS, Melanie Berger, MD, Dana M. Roque, MD, Gautam Rao, MD, Elizabeth M. Nichols, MD, Pranshu Mohindra, MD, MMM
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 4, Pp 101191- (2023)
Purpose: Pelvic reirradiation (re-RT) for patients with gynecologic cancers remains a challenge because of toxicity concerns. Given the dosimetric advantages of proton therapy, we aimed to assess oncologic and toxicity outcomes of patients with re-RT
Externí odkaz:
https://doaj.org/article/c6eeeac819ca4e539b0b6b8a0c7219ce
Autor:
ByongYong Yi, PhD, Sina Mossahebi, PhD, Arezoo Modiri, PhD, Elizabeth M. Nichols, MD, Mariana Guerrero, PhD, Narottam Lamichhane, PhD, Pranshu Mohindra, MD
Publikováno v:
International Journal of Particle Therapy, Pp 31-39 (2022)
Purpose: To investigate whether volumetric-modulated proton arc therapy (VPAT) plans generate comparable doses to organs at risk (OARs) compared with interstitial high– dose-rate (iHDR) brachytherapy for patients with gynecologic cancer with diseas
Externí odkaz:
https://doaj.org/article/8342e9e668704f35ac237810a53239d8
Autor:
Malcolm D. Mattes, MD, Curtiland Deville, Jr, MD, Raymond B. Mailhot Vega, MD, Claire Y. Fung, MD, MS, Gita Suneja, MD, MS, John W. Shumway, Mudit Chowdhary, MD, Chirag Shah, MD, James E. Bates, MD, Pranshu Mohindra, MD, MBBS, Malika L. Siker, MD, Karen M. Winkfield, MD, PhD, Neha Vapiwala, MD, Trevor J. Royce, MD, MS, MPH
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100834- (2022)
ABSTRACT: Purpose: The radiation oncology workforce in the United States is comparatively less diverse than the U.S. population and U.S. medical school graduates. Workforce diversity correlates with higher quality care and outcomes. The purpose of th
Externí odkaz:
https://doaj.org/article/8e725c1b86a740af8336a7bfe6f806fb
Autor:
Aurélien Jongen, MD, Florian Charlier, MD, Kelsey Baker, MS, John Chang, MD, William Hartsell, MD, George Laramore, MD, PhD, Pranshu Mohindra, MD, Luigi Moretti, MD, PhD, Mary Redman, PhD, Lane Rosen, MD, Henry Tsai, MD, Dirk Van Gestel, MD, PhD, Carlos Vargas, MD, Ramesh Rengan, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 1, Pp 100767- (2022)
Purpose: For most disease sites, level 1 evidence is lacking for proton beam therapy (PBT). By identifying target populations that would benefit most from PBT, prospective registries could overcome many of the challenges in clinical trial enrollment.
Externí odkaz:
https://doaj.org/article/cac11c68213547df80e60035caebc60f
Autor:
Melissa A.L. Vyfhuis, MD PhD, Neha Bhooshan, MD PhD, Whitney M. Burrows, MD, Michelle Turner, NP, Mohan Suntharalingam, MD MBA, James Donahue, MD, Elizabeth M. Nichols, MD, Josephine Feliciano, MD, Søren M. Bentzen, PhD DMSc, Shahed Badiyan, MD, Shamus R. Carr, MD, Joseph Friedberg, MD, Charles B. Simone, II, MD, Martin J. Edelman, MD, Steven J. Feigenberg, MD, Pranshu Mohindra, MD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 3, Pp 259-269 (2017)
Purpose: Guidelines for locally advanced non-small cell lung cancer (LA-NSCLC) recommend definitive chemoradiation therapy (CRT) for cN2-N3 disease, reserving surgery for patients with minimal nodal involvement at presentation. The current literature
Externí odkaz:
https://doaj.org/article/034cf0c96c374203aa5b7ace9eafba67
Autor:
Sio TT; Terence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ., Mohindra P; Terence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ., Yu NY; Terence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ., Ashman JB; Terence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ., Daniels TB; Terence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ., Merrell KW; Terence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ., Schild SE; Terence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Oct 10; Vol. 37 (29), pp. 2697-2699. Date of Electronic Publication: 2019 Aug 29.